Molecular Neurodegeneration Impact Factor, Indexing, Ranking

Molecular Neurodegeneration (MN) is a scholarly journal dedicated to publishing research in the field of Neuroscience. BioMed Central is the publisher of this esteemed journal. The P-ISSN assigned to Molecular Neurodegeneration is 1750-1326 and its abbreviated form is Mol Neurodegener.

Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels.

Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and glaucoma. These diseases, which are often associated with advanced aging and display varying degrees of dementia, have become a significant public health issue as humans live longer and the aging population grows larger. Recent advances in the molecular and cellular mechanisms underlying the pathogenesis of these neurodegenerative disorders have allowed for a better understanding of the disease mechanisms.

Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Molecular Neurodegeneration Journal is Mol Neurodegener.

The Ranking of the Journal in 2024 is 253. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.

The Journal's Impact Factor in 2024 is 15.8 . it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors

The Journal SCImago in 2024 is 5.158. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.

The Journal's H-Index in 2024 is 103. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.

The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.

The Journal is indexed in (Indexing details)

• 1. Web of Science
• 2. UGC
• 3. Scopus
• 4. PubMed
• 5. Medline
• 6. Google Scholar
• 7. Embase
• 8. DOAJ

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.

The Editor-in-chief of the Journal is Guojun Bu, USA

Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of the Journal is 2590 EUR, 2990 USD, 2090 GBP

Call for paper : The Journal invites original research contributions for consideration of publication in Molecular Neurodegeneration journal.

Journal seeking submissions in the broad areas of Neuroscience that align with journal's focus on Neuroscience.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.

Publishing in Molecular Neurodegeneration involves the following steps:

• Research: Conduct high-quality, impactful research in the field of Neuroscience.
• Familiarize Yourself: Read and understand the aims and scope of Molecular Neurodegeneration to ensure your work aligns with their focus.
• Manuscript Preparation: Prepare your manuscript according to the Molecular Neurodegeneration guidelines, including formatting, length, and referencing style.
• Submission: Submit your manuscript through the journal's online submission system.

• Journal Website
• PubMed
• Scopus
• SCImago